Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Outer membrane porin PhoE, also known as phosphoporin, is a trimeric beta-barrel protein located in the outer membrane of Gram-negative bacteria, most notably Escherichia coli. It functions as a channel for the passive diffusion of small hydrophilic molecules, exhibiting a distinct selectivity for inorganic phosphate, phosphorylated compounds, and other negatively charged solutes. The expression of PhoE is regulated by the Pho regulon and is significantly upregulated under conditions of phosphate starvation. In clinical medicine, PhoE is a critical component of the bacterial permeability barrier and serves as a primary entry route for several classes of antibiotics, including beta-lactams and fluoroquinolones. Consequently, alterations in PhoE expression or structure are frequently associated with the development of antibiotic resistance in pathogenic bacteria. Beyond its role in transport, PhoE is also investigated as a potential target for vaccine development and as a scaffold for engineering novel drug delivery systems.
Passive diffusion through the porin channel to reach intracellular targets
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Outer membrane porin PhoE (PhoE).